Back to results
US 9,109,245 B2Granted
Cell compositions derived from dedifferentiated reprogrammed cells
AssigneeViaCyte, Inc.
InventorsAlan D. Agulnick, Olivia Kelly, Yuki Ohi, Allan Robins, Thomas Schultz
Life of this patent
Estimating the term…
Abstract
Disclosed herein are cell culture compositions, for example, pancreatic cell culture compositions, derived from dedifferentiated human reprogrammed pluripotent stem cells, such as induced pluripotent stem (iPS) cells, and methods for producing and using such cell culture compositions.
Claims8
An in vitro human pancreatic endoderm cell population in a media comprising an ERBB receptor tyrosine kinase activating agent.
Dependencies are inferred from the claim text.